Marina Kras, PA
Medical · Middlefield, OHNPI 1891406427
Payments from drug & device makers
Across 96 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$520
- Novo Nordisk$146
- AstraZeneca$144
- Pfizer$116
- Lilly USA, LLC$101
- Otsuka America Pharmaceutical, Inc.$96
- plus $748 from 17 others
What the payments were for
- Food & beverage$1,870100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $520 |
| Novo Nordisk | 8 | $146 |
| AstraZeneca | 8 | $144 |
| Pfizer | 7 | $116 |
| Lilly USA, LLC | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $79 |
| Exact Sciences | 4 | $74 |
| GSK | 4 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Bayer | 2 | $52 |
| Astellas Pharma US Inc | 2 | $46 |
| Johnson & Johnson | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Boehringer Ingelheim | 3 | $42 |
| Lundbeck LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Mylan Specialty L.p. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
How this compares
$1,870 in reported general payments places this provider in the 75th percentile of 547 medical providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $530 |
| Amlodipine Besylate | 48 | $463 |
| Montelukast Sodium | 18 | $427 |
| Losartan Potassium | 33 | $276 |
| Omeprazole | 18 | $246 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $207 |
| Rosuvastatin Calcium | 30 | $199 |
| Atorvastatin Calcium | 18 | $194 |
| Doxycycline Hyclate | 13 | $171 |
| Levothyroxine Sodium | 29 | $158 |
| Pantoprazole Sodium | 16 | $144 |
| Escitalopram Oxalate | 19 | $125 |
| Lisinopril | 18 | $115 |
| Metformin Hcl | 21 | $98 |
| Hydrochlorothiazide | 14 | $92 |
Paid to pharmacies, not to this prescriber.
Other medical in Middlefield
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.